$PG

Jejurikar Shailesh sold $888K of PG

Jejurikar Shailesh (Chairman, President and CEO) sold 6,176 shares of PROCTER & GAMBLE Co (PG) at $143.79 ($0.89M total) on 2026-08-20.

Original reporting
SEC EDGAR · Jejurikar Shailesh
Published Aug 24, 2026, 7:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PG
Neutral
medium confidence
Mentioned
$PG
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGNeutralLow
01

Why it matters

The sale is a primary disclosure; modest size limits market impact.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

CEO may be reallocating capital; no change in company fundamentals.

Relevance 5/10Novelty 4/10Timing: post filing

Background

SEC Form 4 disclosed the insider transaction.

Company-level read

Ticker impact

$PGNeutralMedium confidence
Context

CEO Shailesh Jejurikar sold 6,176 shares of Procter & Gamble for $888K, reducing his stake to 39,326 shares.

Expected impact

Potential slight downward pressure if market interprets as negative signal.

Evidence & confidence

Form 4 filing is primary source; $888K sale by CEO is material enough for short-term traders but not large enough to drive major price moves.

Market effects

Minimal impact on consumer staples sector.

None

Low

Counterpoint

Insider sell could be routine diversification, not a negative signal.

Key entities

  • Procter & Gamble Co

    Consumer goods conglomerate (ticker PG).

  • Shailesh Jejurikar

    Chairman, President and CEO of Procter & Gamble.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PGMed

P&G Is Betting $3.8 Billion on Wellness. Can It Offset a $1 Billion Cost Headwind?

Procter & Gamble (PG) reported fiscal 2026 organic sales growth of 1% and core EPS of $6.89. For fiscal 2027, PG guided organic sales growth of 1% to 3% and core EPS growth of 0% to 3%, citing a $1 billion cost headwind from higher raw materials, energy, and transportation costs. PG acquired Thorne, a premium supplements brand, to offset some pressure. Analysts estimate a target price of $180, implying 22.7% upside over 2.8 years. PG's performance is compared to peers like Colgate-Palmolive (CL)

$PGLow

Procter & Gamble Margins Under Pressure: Time to Stay Cautious?

Procter & Gamble (PG) faces margin pressure from rising costs, expecting a $1.4B after-tax earnings headwind in fiscal 2027. Despite productivity initiatives, Q1 EPS is forecast to decline 5%. Competitors Colgate-Palmolive (CL) and Clorox (CLX) are also implementing cost-saving measures. PG's stock is up 1.7% in 3 months, trading at a forward P/E of 20.72X.

$PGMed

Weather Dividend Stocks That Keep Writing Bigger Checks

Procter & Gamble (PG) raised its dividend for 70 consecutive years, with fiscal 2026 free cash flow of $15.835B. Coca-Cola (KO) reported 5% unit case volume growth, its strongest in 17 years. Colgate-Palmolive (CL) saw 16.12% YTD stock growth and raised its dividend. All three companies demonstrated recession-resilient cash flows and dividend increases.

$PGMed

Toilet paper becomes an issue for Trump again as Canada's tariffs could spell another shortage

Canada imposed 25-50% tariffs on U.S. paper products, including toilet paper, in response to U.S. tariffs on Canadian goods. Procter & Gamble (P&G) expects a $0.25-per-share earnings hit and plans price increases. Canada supplied $328M of toilet paper to the U.S. in 2024, with Canadian pulp crucial for U.S. production. U.S. consumers bear 96% of tariff costs, per Fed research.

$PGMed

Procter & Gamble outlook raised to positive by Moody’s on cash flow

Moody’s affirmed Procter & Gamble’s (PG) ratings and changed the outlook to positive, citing strong cash flow, earnings growth, and stable credit metrics. The upgrade reflects P&G’s ability to generate positive free cash flow and earnings growth through pricing, innovation, and cost savings. Moody’s expects leverage to rise slightly due to the Thorne acquisition but return to low levels through optimization. The ratings could be upgraded if P&G maintains its strong operating profile and profitab